[
  {
    "ts": null,
    "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
    "summary": "Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI bubble continue to mount. Tuesday’s sell-off follows a wild start to the week, during which the Dow Jones Industrial Average traded lower due ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
    "url": "https://finnhub.io/api/news?id=59597ebe0178c938e383ee4aeba1c88a882b09f5aeee9d1fde3ffaa6ed1606af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762265503,
      "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
      "id": 137311824,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite beating earnings expectations and giving strong forward guidance. Concerns over an AI bubble continue to mount. Tuesday’s sell-off follows a wild start to the week, during which the Dow Jones Industrial Average traded lower due ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More",
      "url": "https://finnhub.io/api/news?id=59597ebe0178c938e383ee4aeba1c88a882b09f5aeee9d1fde3ffaa6ed1606af"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: The Market Is Still Worried, And That's Good For Buyers",
    "summary": "UnitedHealth Group stock offers strong growth forecasts that make UNH a compelling \"Buy.\" Click here to read an analysis of UNH stock now.",
    "url": "https://finnhub.io/api/news?id=bcc693aef1f5c63ffc4bb1fb4a931edcd6dee33aa147263488c74fc092619117",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762262324,
      "headline": "UnitedHealth: The Market Is Still Worried, And That's Good For Buyers",
      "id": 137316313,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442861078/image_1442861078.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth Group stock offers strong growth forecasts that make UNH a compelling \"Buy.\" Click here to read an analysis of UNH stock now.",
      "url": "https://finnhub.io/api/news?id=bcc693aef1f5c63ffc4bb1fb4a931edcd6dee33aa147263488c74fc092619117"
    }
  },
  {
    "ts": null,
    "headline": "Does UnitedHealth’s 33.8% Drop Signal Opportunity After Recent Regulatory Headlines?",
    "summary": "Ever wondered if UnitedHealth Group’s stock is a true bargain or just riding on reputation? Take a closer look at what the numbers are really saying. After a rough patch, the stock dropped by 8.8% in the past week and is down 33.8% so far this year. This has sparked plenty of questions about its future and the sentiment driving those moves. Several headlines have caught investors' attention lately, including regulatory changes and shifts in healthcare policy that are fueling increased...",
    "url": "https://finnhub.io/api/news?id=7c50d0c22e2bb3d494c0580d562a47cc3c2ecc59584544ad58f97e293fee59a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762243941,
      "headline": "Does UnitedHealth’s 33.8% Drop Signal Opportunity After Recent Regulatory Headlines?",
      "id": 137312148,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Ever wondered if UnitedHealth Group’s stock is a true bargain or just riding on reputation? Take a closer look at what the numbers are really saying. After a rough patch, the stock dropped by 8.8% in the past week and is down 33.8% so far this year. This has sparked plenty of questions about its future and the sentiment driving those moves. Several headlines have caught investors' attention lately, including regulatory changes and shifts in healthcare policy that are fueling increased...",
      "url": "https://finnhub.io/api/news?id=7c50d0c22e2bb3d494c0580d562a47cc3c2ecc59584544ad58f97e293fee59a1"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From UnitedHealth’s Q3 Earnings Call",
    "summary": "UnitedHealth’s third quarter results were shaped by ongoing margin pressure and the company’s efforts to address underperformance in key segments. Management attributed the quarter’s operational challenges primarily to the lingering effects of medical cost trends, especially in Medicare Advantage and Medicaid, as well as ongoing investments to restructure underperforming businesses. CEO Stephen Hemsley acknowledged, “We’re getting at the core of the underperformance issues with fresh perspective",
    "url": "https://finnhub.io/api/news?id=b43cc0a4d97540c79530a98c1e6a52240c30640e08cda22e281fb90ad6256b4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762234639,
      "headline": "The Top 5 Analyst Questions From UnitedHealth’s Q3 Earnings Call",
      "id": 137312149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth’s third quarter results were shaped by ongoing margin pressure and the company’s efforts to address underperformance in key segments. Management attributed the quarter’s operational challenges primarily to the lingering effects of medical cost trends, especially in Medicare Advantage and Medicaid, as well as ongoing investments to restructure underperforming businesses. CEO Stephen Hemsley acknowledged, “We’re getting at the core of the underperformance issues with fresh perspective",
      "url": "https://finnhub.io/api/news?id=b43cc0a4d97540c79530a98c1e6a52240c30640e08cda22e281fb90ad6256b4c"
    }
  },
  {
    "ts": null,
    "headline": "At The Halfway Mark, S&P 500 Earnings Defy Headwinds As Tech And Health Care Deliver Strong Q3",
    "summary": "Q3 earnings growth continues to improve. With 64% of constituents reporting thus far, S&P 500 EPS growth for the quarter accelerated to 10.7%. This marks the second peak week of Q3 earnings.",
    "url": "https://finnhub.io/api/news?id=1e6a1f18d4ed032290e41221e4d3240752f97cff7a11be60e9f86aa75e21494c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762230600,
      "headline": "At The Halfway Mark, S&P 500 Earnings Defy Headwinds As Tech And Health Care Deliver Strong Q3",
      "id": 137310695,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2221411629/image_2221411629.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "Q3 earnings growth continues to improve. With 64% of constituents reporting thus far, S&P 500 EPS growth for the quarter accelerated to 10.7%. This marks the second peak week of Q3 earnings.",
      "url": "https://finnhub.io/api/news?id=1e6a1f18d4ed032290e41221e4d3240752f97cff7a11be60e9f86aa75e21494c"
    }
  }
]